End-of-day quote
Thailand S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
8.15
THB
|
-0.61%
|
|
+1.24%
|
+21.64%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
108,587
|
86,614
|
28,652
|
19,197
|
23,351
|
-
|
-
|
Enterprise Value (EV)
1 |
90,727
|
74,160
|
23,187
|
19,197
|
23,351
|
23,351
|
23,351
|
P/E ratio
|
6.41
x
|
3.65
x
|
17.2
x
|
-
|
-
|
-
|
-
|
Yield
|
5.26%
|
15.4%
|
7.5%
|
-
|
2.21%
|
3.8%
|
6.38%
|
Capitalization / Revenue
|
3.57
x
|
1.82
x
|
1.23
x
|
0.98
x
|
1.01
x
|
0.9
x
|
0.79
x
|
EV / Revenue
|
3.57
x
|
1.82
x
|
1.23
x
|
0.98
x
|
1.01
x
|
0.9
x
|
0.79
x
|
EV / EBITDA
|
6.34
x
|
3.18
x
|
8.14
x
|
8.23
x
|
8.44
x
|
6.21
x
|
4.46
x
|
EV / FCF
|
9,396,860
x
|
6,453,224
x
|
-9,579,939
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
3.43
x
|
2.27
x
|
0.78
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,857,560
|
2,863,261
|
2,865,180
|
2,865,180
|
2,865,180
|
-
|
-
|
Reference price
2 |
38.00
|
30.25
|
10.00
|
6.700
|
8.150
|
8.150
|
8.150
|
Announcement Date
|
2/16/21
|
2/17/22
|
2/17/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,994
|
30,405
|
47,551
|
23,305
|
19,665
|
23,008
|
25,935
|
29,543
|
EBITDA
1 |
-
|
17,121
|
27,263
|
3,520
|
2,333
|
2,766
|
3,761
|
5,240
|
EBIT
1 |
-
|
16,049
|
26,016
|
1,909
|
115.8
|
1,156
|
2,064
|
3,453
|
Operating Margin
|
-
|
52.79%
|
54.71%
|
8.19%
|
0.59%
|
5.02%
|
7.96%
|
11.69%
|
Earnings before Tax (EBT)
|
-
|
15,946
|
25,877
|
1,884
|
-
|
-
|
-
|
-
|
Net income
|
634.3
|
14,401
|
23,704
|
1,652
|
-
|
-
|
-
|
-
|
Net margin
|
5.29%
|
47.36%
|
49.85%
|
7.09%
|
-
|
-
|
-
|
-
|
EPS
|
0.4150
|
5.930
|
8.280
|
0.5800
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
11,556
|
13,422
|
-2,991
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
38.01%
|
28.23%
|
-12.83%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
67.49%
|
49.23%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
80.24%
|
56.62%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
2.000
|
4.650
|
0.7500
|
-
|
0.1800
|
0.3100
|
0.5200
|
Announcement Date
|
7/1/20
|
2/16/21
|
2/17/22
|
2/17/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
---|
Net sales
1 |
-
|
10,864
|
8,285
|
7,118
|
6,542
|
-
|
EBITDA
1 |
-
|
5,308
|
2,158
|
1,435
|
1,380
|
-
|
EBIT
1 |
-
|
4,999
|
1,817
|
1,102
|
695.2
|
-
|
Operating Margin
|
-
|
46.02%
|
21.93%
|
15.48%
|
10.63%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
4,982
|
1,972
|
1,182
|
681.5
|
-
|
Net income
1 |
17,332
|
4,533
|
1,840
|
1,052
|
616.5
|
1,669
|
Net margin
|
-
|
41.72%
|
22.2%
|
14.78%
|
9.42%
|
-
|
EPS
2 |
6.060
|
1.580
|
0.6400
|
0.3700
|
0.2200
|
0.5800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/10/21
|
11/8/21
|
2/17/22
|
5/9/22
|
8/10/22
|
8/10/22
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
17,860
|
12,453
|
5,465
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
11,556
|
13,422
|
-2,991
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
79.8%
|
67.3%
|
4.4%
|
0.41%
|
2.74%
|
4.73%
|
7.64%
|
ROA (Net income/ Total Assets)
|
-
|
51.1%
|
49.6%
|
3.31%
|
-
|
-
|
-
|
-
|
Assets
|
-
|
28,204
|
47,769
|
49,916
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
11.10
|
13.30
|
12.80
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
5.610
|
8.410
|
1.430
|
-
|
-
|
-
|
-
|
Capex
|
-
|
2,055
|
10,649
|
7,076
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
6.76%
|
22.4%
|
30.36%
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/1/20
|
2/16/21
|
2/17/22
|
2/17/23
|
2/16/24
|
-
|
-
|
-
|
Last Close Price
8.15
THB Average target price
12.5
THB Spread / Average Target +53.37% Consensus |
1st Jan change
|
Capi.
|
---|
| +21.64% | 631M | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -13.37% | 1.83B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +4.01% | 1.13B |
Medical Supplies
|